ONLINE DAT Benzodiazepines II— 510(k) K221765

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K221765 for ONLINE DAT Benzodiazepines II, Substantially Equivalent on 2022-12-23. Applicant: Roche Diagnostics.

Clearance details

Applicant: Roche Diagnostics
Product code: Code JXM
Advisory panel: Clinical Toxicology
Date received: 2022-06-17
Decision date: 2022-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.